Short Interest in ALK-Abelló A/S (OTCMKTS:AKBLF) Expands By 75.2%

ALK-Abelló A/S (OTCMKTS:AKBLF) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totaling 126,792 shares, a growth of 75.2% from the April 30th total of 72,390 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

ALK-Abelló A/S Price Performance

Shares of AKBLF stock opened at $38.89 on Tuesday. The business’s 50-day moving average price is $34.55 and its 200-day moving average price is $35.05. ALK-Abelló A/S has a 12 month low of $26.99 and a 12 month high of $38.89.

About ALK-Abelló A/S

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.